Due to over-nutrition and lack of exercise, the number of overweight and obese people in the world had surged in the past three decades, and is becoming one of the most serious public health problems worldwide. Extensive epidemiological studies reveal that obesity has major impacts on both the type and incidence of cancers. However, the exact molecular mechanisms underlying obesity-associated cancer are not fully understood yet. Using mouse models, we have recently found that dietary or genetic obesity provokes alterations of gut microbiota profile, thereby increasing the levels of deoxycholic acid (DCA), a gut microbial metabolite produced solely by the 7α-dehydroxylation of primary bile acids. The enterohepatic circulation of DCA increases the levels of DCA in liver and provokes DNA damage-induced cellular senescence in hepatic stellate cells (HSCs), which in turn, secretes various inflammatory and tumor promoting factors in the liver, thus facilitating hepatocellular carcinoma (HCC) development in obese mice. Notably, signs of cellular senescence and associated secretory phenotypes were also observed in the HSCs in the area of HCC arising in patients with non-alcoholic steatohepatitis (NASH) without cirrhosis, implying that a similar pathway is likely to contribute to at least certain aspects of obesity-associated HCC development in humans as well. In this review, we will provide an overview of our recent work and discuss the next steps, toward potential clinical applications of our findings.
Introduction
Over the past decades, human life expectancy has increased dramatically and people are now living longer, especially in developed countries. For example, average lifespan of most developed countries is around double compared with 100 years ago 1) . Ironically, however, extended lifespan has resulted in a startling rise in the incidence of age-related illnesses, such as cancer 2) . For instance, in Japan, now half the population will develop cancer in their lifetime and one-third of the population die of cancer. Thus, to have a meaningful impact on the extended lifespan, there is an urgent need for increased understanding of the molecular mechanisms underlying increased incidence of cancer in modern world.
Due to over-nutrition and lack of exercise, the number of overweight (defined as a body-mass index [BMI] of 25 to 29.9 kg/m 2 ) and obese (BMI of 30 kg/m 2 or greater) people in the world had surged in the past three decades.
Multiple epidemiological studies have revealed that excess bodyweight is a major risk factor for not only diabetes and cardiovascular diseases but also cancer 3, 4) . Although weight loss by exercise and/or dietary control ameliorates obesityinduced metabolic syndromes, the worldwide obesity epidemic has shown no signs of abating 5, 6) . Therefore, more effective methods are required to prevent obesityassociated cancer development. Towards this purpose, better understanding of the mechanisms underlying obesityassociated cancer is urgently required.
Cellular senescence is a process occurring in normal cells in response to telomere erosion or oncogene activation, acting through checkpoint activation and stable cell cycle arrest as a barrier to tumorigenesis [7] [8] [9] [10] [11] [12] [13] . Recent studies, however, reveal that senescent cells also develop a secretory profile composed mainly of inflammatory cytokines, chemokines and proteases, a typical signature termed the senescence-associated secretory phenotype (SASP) 14, 15) or the senescence messaging secretome (SMS) 16) , hereafter referred to as SASP. Some of the SASP factors display cellautonomous activities to reinforce senescence cell cycle arrest 17,18) and/or promote tumor clearance [19] [20] [21] . Other SASP factors exhibit cell-nonautonomous functions associated with inflammation and tumorigenesis promotion 14) , indicating that SASP contributes positively and negatively to cancer development, depending on the biological context 15) . Since some of the SASP factors, such as IL-6 and PAI-1, are known to increase cancer risk in obesity 4, 22) , we have set up the system to explore the possibility that SASP may contribute to obesity-associated cancer development using wild-type C57BL/6 mice.
Dietary or genetic obesity induces cellular senescence in liver
In contrast to human epidemiological studies, we were unable to detect any statistically significant difference in cancer development between obese mice fed a high fat diet (HFD) and lean mice fed a normal diet (ND .
Although we were unable to detect two widely used cellular senescence markers, senescence-associated β-galactosidase (SA-β-gal) activity and senescenceassociated heterochromatic foci (SAHF) 26, 27) , in the HSCs . Moreover, accumulating evidence has indicated that SA-β-gal and SAHF are not always associated with cellular senescence [28] [29] [30] [31] [32] . These findings, together with our observations of similar results in genetically obese (Lep ob/ob ) mice, suggested that obesity provokes senescence-like .
Senescent HSCs promotes HCC development through SASP in obese mice
To clarify the roles of the senescence-like features in the HSCs, we repeated the same experiments using mice lacking IL-1β, a critical inducer of SASP 33, 34) . Interestingly, although the degrees of DNA damage and cell cycle arrest in HSCs were unchanged, significant reductions of SASP in HSCs and HCC development were observed, implying that SASP plays crucial roles in HCC development in obese mice 25) . To obtain further support for this idea, we attempted to generate conditional knockout mice lacking IL-1β only in HSCs. However, there are currently no reports of genes expressed only in HSCs. Moreover, quiescent HSCs are known to be capable of functioning as multi-potent progenitors and producing hepatocytes in adult livers 35) , thus making it difficult to generate HSCspecific knockout mice. Therefore, we tried an alternative approach, the siRNA-mediated depletion of HSCs 36) , and obtained the same results 25) , indicating that senescent 
DCA, an obesity associated gut microbial metabolite provokes cellular senescence in HSCs
How does obesity provoke the senescence-like features in HSCs? It has recently become apparent that alterations of the gut microbiota are associated with obesity in both humans and mice 40, 41) . Furthermore, the activation of toll- . The DCA is the most common secondary bile acid and carries the fat in the same way as original (primary) bile acids and follows the same path from gut to liver 43) . But, it can cause DNA damage 44) . Moreover, in addition to colon carcinogenesis, DCA has been shown to enhance liver carcinogenesis 45) . We therefore next focused on DCA. Interestingly, DFAIII-mediated suppression of the .
Notably, an operational taxonomic unit (OTU)-based bacterial diversity analysis, in conjunction with a quantitative PCR analysis, revealed that the population of Clostridium cluster XI was strikingly increased in obese mice 25) .
Interestingly, a phylogenetic analysis of the bacterial OTUs revealed that Clostridium cluster XI is composed of a single bacterial taxon (OUT-1105) close to the DCA-producing strain Clostridium hiranonis and Clostridium sordellii 43) .
Thus, although other bacteria may also participate, the simplest explanation for our data is that OUT-1105 contributes to an increase in the DCA level, at least to some extent, in obese mice.
SASP in human NASH-associated liver cancer
To further support and extend our murine data to human biology, we asked whether our observations could be applied to humans. Note that at least five studies have found that obesity increases (by 1.5-to 4-fold) the risk of liver cancer 3, [46] [47] [48] [49] . Moreover, in the setting of chronic hepatitis B or C infection, coexisting obesity has been shown to increase the risk for HCC by more than 100-fold 50) . It should also be noted that obesity is a major cause of non-alcoholic steatohepatitis (NASH) and NASH is a risk factor for liver cancer 51, 52) . Taken together, although the magnitude of the observed relative risk from existing studies is not consistent, it is clear that obesity increases the risk of liver cancer. These reports, together with the observations that the relative proportion of Firmicutes (Gram-positive bacteria) in gut microbiota is reportedly increased in obese people 40) and high fat consumption causes higher fecal DCA concentrations in healthy volunteers 53, 54) , prompted us to examine whether SASP is also associated with human obesity-induced liver cancers. 
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arises from the non-cirrhotic liver 55) and HSCs exhibit proinflammatory phenotype rather than fibrogenic phenotype during cellular senescence 56) . Although we do not have a
definitive answer yet, these findings, in conjunction with published reports 22, 40, 45, 53, 54, 56, 57) , led us to have an idea that senescent HSCs may contribute to at least certain aspects of obesity-associated HCC development in human as well (see model in Fig. 2 ).
Concluding remarks and Directions for future research
Several issues remain to be resolved. , it is most likely that obesity, but not the HFD feeding, increases the population of DCA-producing gut bacteria. We are currently investigating the mechanism underlying the obesity-associated increase of DCA producing gut bacteria.
Finally, we need to determine whether the population of DCA-producing gut bacteria is increased by obesity in humans, and if so, how this occurs. To address these issues, we are now collecting clinical samples to determine whether the levels of DCA and/or DCA-producing bacteria are higher in obese individuals than in non-obese individuals. 
